Alexis Sharabaika

Alexis Sharabaika is a seasoned professional in the field of pricing and contracting within market access, currently serving as Senior Director at Sage Therapeutics since July 2019, following a tenure at HighPoint Solutions spanning over a decade in various leadership roles. Prior experience includes positions such as Senior Consultant at Computer Sciences Corporation and IMS Consulting, as well as a consultant role at Envision. Educational qualifications include a Bachelor of Arts in International Relations and French from Tufts University and an MBA in Marketing from the University of Maryland - Robert H. Smith School of Business.